-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Objective: Anti-synthetase syndrome (ASyS) and dermatomyositis (DM) are clinically overlapping autoimmune diseas.
Objective: Anti-synthetase syndrome (ASyS) and dermatomyositis (DM) are clinically overlapping autoimmune diseas.
METHODS: Five patients with ASys and seven patients with DM were recruitedfrom a prospectively collected database of patients with definitively diagnosed D.
Results: IF staining of MxA and IFNβ expression showed that type I IFN was upregulated in ASyS and DM samples compared with healthy control samples ( P < 05 .
Conclusions: IMC is a powerful tool to identify the role of the type I IFN system in DM - like skin lesions in ASyS and D.
Source: Patel,.
Patel,.
, Ravishankar,.
, Maddukuri,.
, Vazquez,.
, Grinnell,.
and Werth, VP (2022), Identification of Similarities Between Skin Lesions in Patients With Antisynthetase Syndrome and Skin Lesions in Patients With Dermatomyositis by Highly Multiplexed Imaging Mass Cytomet.
Arthritis Rheumatol, 74: 882-89https://d.
org/11002/a.
42050 https://d.
org/11002/a.
42050Leave a comment here